Back to Search
ABRAHAM LINCOFF, MD
MD
Cardiovascular Disease Physician
NPI: 1427141902IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
35065025L(OH)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1986
Research & Publications (20)
Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
PMID 19463378·JACC Cardiovasc Interv·2008
4-observational
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
PMID 18574276·Chest·2008
6-review
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
PMID 18574270·Chest·2008
6-review
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
PMID 17848652·JAMA·2007
1-meta
How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?
PMID 16729004·Nat Clin Pract Cardiovasc Med·2006
8-other
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.
PMID 15304466·JAMA·2004
3-trial
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
PMID 15110198·Am J Cardiol·2004
3-trial
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
PMID 14564303·Am Heart J·2003
6-review
Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade.
PMID 12654616·Circulation·2003
6-review
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
PMID 12588269·JAMA·2003
3-trial
Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
PMID 12439432·Rev Cardiovasc Med·2002
6-review
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
PMID 12413372·JAMA·2002
3-trial
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).
PMID 12040347·Am Heart J·2002
3-trial
Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction.
PMID 11847401·J Invasive Cardiol·2002
8-other
Combination therapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa receptor inhibitors: SPEEDing into GUSTO V.
PMID 11458014·J Invasive Cardiol·2001
8-other
Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.
PMID 11447080·Circulation·2001
3-trial
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
PMID 11113041·Circulation·2000
3-trial
GUSTO IV: expanding therapeutic options in acute coronary syndromes.
PMID 11100004·Am Heart J·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1427141902
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile